𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CT of the chest and abdomen in patients with newly diagnosed head and neck squamous cell carcinoma

✍ Scribed by Harri T. Keski-Säntti; Antti T. O. Markkola; Antti A. Mäkitie; Leif J. J. Bäck; Timo S. Atula

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
117 KB
Volume
27
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

The benefits of ct scanning of the chest and abdomen as a routine screening method for patients with newly diagnosed head and neck squamous cell carcinoma (hnscc) remain unclear.

Methods:

Consecutive patients with a primary hnscc (t classification, t2-t4) and or regionally metastatic disease (ie, n+) were eligible for inclusion. patients who were considered incurable and patients with recurrent disease were excluded. ct scans of the chest and abdomen were performed.

Results:

We examined 100 patients. two patients had pulmonary metastases at presentation. an occult aortic aneurysm required surgical repair before anticancer therapy in one patient. in many patients, nonspecific ct findings warranted further examinations or close follow-up. the abdominal ct was negative for metastatic hnscc in all patients.

Conclusions:

Routine ct screening of the chest and abdomen resulted in upstaging of disease in two patients (2%) and altered the treatment approach in three patients (3%). abdominal ct does not seem beneficial in patients with previously untreated hnscc. chest ct is not indicated routinely.

📜 SIMILAR VOLUMES

Pharmacodynamic evaluation of temsirolim
Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma
✍ Oleksandr Ekshyyan; Glenn M. Mills; Timothy Lian; Nazanin Amirghahari; Xiaohua R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract ## Background: Activation of the mammalian target of rapamycin (mTOR) pathway in surgical margins of head and neck squamous cell carcinoma (HNSCC) is a predictor of recurrence and patients with minimal residual disease may benefit from adjuvant therapy with temsirolimus, an mTOR inhibi

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Immunoglobulin allotypes in patients wit
Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck
✍ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant

Radioimmunotherapy in patients with head
Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience
✍ David R. Colnot; Jasper J. Quak; Jan C. Roos; Remco de Bree; Abraham J. Wilhelm; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Abstract ## Background Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), local and distant failure rates remain high. An effective adjuvant therapy is required for these patients. Among novel approaches is radioimmunotherapy, i